Discovery of circadian clock activators with anti-obesity efficacy via suppression of adipocyte development and hypertrophy.

Xiong X, Pangemanan J, Kiperman T, Fang Z, Agua A, Huang W, Horne D, Ma K

Open source

DOI
10.1016/j.ymthe.2026.06.038
Published
2026 Sep 2
Container
Molecular therapy : the journal of the American Society of Gene Therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ymthe.2026.06.038,
  title = {Discovery of circadian clock activators with anti-obesity efficacy via suppression of adipocyte development and hypertrophy.},
  author = {Xiong X and Pangemanan J and Kiperman T and Fang Z and Agua A and Huang W and Horne D and Ma K},
  year = {2026},
  journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
  doi = {10.1016/j.ymthe.2026.06.038},
  url = {https://doi.org/10.1016/j.ymthe.2026.06.038}
}

RIS

TY  - JOUR
TI  - Discovery of circadian clock activators with anti-obesity efficacy via suppression of adipocyte development and hypertrophy.
AU  - Xiong X
AU  - Pangemanan J
AU  - Kiperman T
AU  - Fang Z
AU  - Agua A
AU  - Huang W
AU  - Horne D
AU  - Ma K
PY  - 2026
JO  - Molecular therapy : the journal of the American Society of Gene Therapy
DO  - 10.1016/j.ymthe.2026.06.038
UR  - https://doi.org/10.1016/j.ymthe.2026.06.038
ER  - 

APA

X, X., J, P., T, K., Z, F., A, A., W, H., D, H., & K, M. (2026). Discovery of circadian clock activators with anti-obesity efficacy via suppression of adipocyte development and hypertrophy.. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2026.06.038

Source records